Business Wire

ALIBABA-CLOUD

Share
Alibaba Cloud Showcases Wuying Cloudbook at Apsara Conference

Alibaba Cloud, the digital technology and intelligence backbone of Alibaba Group, will be showcasing the new additions to its cloud computer offering at its Apsara Conference. The Wuying Cloudbook, empowered by Wuying Architecture, is designed to provide enterprises with unlimited computing power while helping them enhance data security, improve cost efficiency and facilitate collaboration in increasingly diverse hybrid office settings.

Drawing on the high levels of security, scalability and compatibility that characterize the cloud, the Wuying Cloudbook allows users to fully leverage the power of cloud computing while minimizing the workload for local devices. Users can scale computing power and storage up or down to meet their demands as and when they need, getting rid of the capacity restrictions of running large-scale software, such as video-rendering software, and enjoying a real-time interactive experience with low latency and high-quality images.

Wuying Cloudbook supports secure storage and transmission of massive volumes of organizational resources by centralizing and managing them in the cloud. It overcomes typical security challenges in enterprise environments, such as data loss and local device vulnerabilities, while allowing users to access organizational resources at any time, anywhere.

Wuying Cloudbook also extends the boundaries of collaboration, allowing users to run multiple operating systems, including Windows, Linux, or Android on it simultaneously. As the software is also deployed and running in the cloud, there is no need to download and install software on local devices, minimizing the requirement for storage capacity and the battery consumption of local devices. Wuying Cloudbook is an ideal choice for new ways of working, such as remote working, outsourcing, and collaboration between teams in different locations.

The scalability, security and flexibility of Wuying Cloudbook is supported by Alibaba Cloud’s Wuying Architecture, which is designed to optimize workload collaboration between cloud and local devices. The industry-leading architecture is compatible with devices ranging from laptops and tablets to any hardware that demands robust computing power. Leveraging this architecture, users can access unlimited computing power and storage capacity in any computing terminal.

Wuying Architecture is a powerful extension and expansion of the workplace. It helps enterprises to enhance flexibility and improve operational efficiency. Taking advantage of cloud-based data security capabilities and tools, Wuying provides additional assurance to safeguarding corporate information security,” said Jiangwei JIANG, Senior Researcher and General Manager of Infrastructure Products, Alibaba Cloud Intelligence. “Thanks to its compatibility, Wuying Architecture brings the benefits of cloud computing to hardware brands, software vendors and enterprises, as well as individual users.”

The Wuying Cloudbook, will be demonstrated at the exhibition area at Alibaba Cloud’s Apsara Conference, features an ultra-thin body just 13.9mm deep and a 14-inch touch-screen. An unboxing video, giving a preview of the device, is available here. With this new addition, Alibaba Cloud now offers cloud computing in the form of a card, a box, an all-in-one PC, a laptop and a Desktop-as-a Service (DaaS) application.

Customer experiences with Wuying: Automotive and Education

In China, IM Motors, an intelligent electric vehicle company, is the first in the automobile industry to adopt Wuying in product design. At the R&D stage, teams in different locations need to collaborate closely. Using Wuying, the design documents can be accessed by multiple teams in multiple locations.

“The automobile industry traditionally relied heavily on offline collaboration, as large-scale workstations were necessary for many work processes. Wuying is a dream come true for our sector. Not only does it offer the necessary computing power to support the intense workload, but it also eases our anxiety around data security when transmitting and sharing confidential design files, allowing us to focus our attention on the design itself,” said Jiao XIANG, Executive Director of Intelligence Research Center, IM Motors.

East China Normal University is one of the early adopters of Wuying in education. The cloud computer has replaced traditional server rooms in research projects, allowing students to work seamlessly on their projects when they move from laboratories to classrooms and dormitories, as the research data has been centralized in the cloud. Research efficiency has also been greatly improved by running data analytics on the cloud.

“This mobile research mode offered by Wuying has proven to be very valuable for professors and students alike. On-the-cloud laboratories provide unlimited computing power, overcoming the limitations of latency and bandwidth in a localized setting. In addition, it’s a powerful, 24/7 service, which helps us obtain research results in a much shorter time,” said Wei WANG, professor of the School of Data Science and Engineering, East China Normal University.

Apsara Conference opens tomorrow

As well as showcasing the Wuying Cloudbook, Alibaba Cloud’s annual Apsara Conference, which opens on November 3 in Hangzhou and runs until November 5, will shed light on the tech leader’s business strategy, products and partnerships.

About Alibaba Cloud

Established in 2009, Alibaba Cloud (www.alibabacloud.com) is the digital technology and intelligence backbone of Alibaba Group. It offers a complete suite of cloud services to customers worldwide, including elastic computing, database, storage, network virtualization services, large-scale computing, security, management and application services, big data analytics, a machine learning platform and IoT services. Alibaba maintained its position as the third leading public cloud IaaS service provider globally since 2018, according to IDC. Alibaba is the world’s third leading and Asia Pacific’s leading IaaS provider by revenue in U.S. dollars since 2018, according to Gartner.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221101006400/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release

Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem

Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release

Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played

Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release

At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will

Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release

Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release

MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye